annual EBITDA:
$9.30B-$163.00M(-1.72%)Summary
- As of today (August 26, 2025), ELV annual EBITDA is $9.30 billion, with the most recent change of -$163.00 million (-1.72%) on December 31, 2024.
- During the last 3 years, ELV annual EBITDA has risen by +$70.00 million (+0.76%).
- ELV annual EBITDA is now -1.72% below its all-time high of $9.46 billion, reached on December 31, 2023.
Performance
ELV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$2.67B-$498.00M(-15.71%)Summary
- As of today (August 26, 2025), ELV quarterly EBITDA is $2.67 billion, with the most recent change of -$498.00 million (-15.71%) on June 30, 2025.
- Over the past year, ELV quarterly EBITDA has dropped by -$649.00 million (-19.54%).
- ELV quarterly EBITDA is now -40.31% below its all-time high of $4.48 billion, reached on December 31, 2009.
Performance
ELV quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$8.55B-$649.00M(-7.06%)Summary
- As of today (August 26, 2025), ELV TTM EBITDA is $8.55 billion, with the most recent change of -$649.00 million (-7.06%) on June 30, 2025.
- Over the past year, ELV TTM EBITDA has dropped by -$1.55 billion (-15.33%).
- ELV TTM EBITDA is now -15.33% below its all-time high of $10.10 billion, reached on June 30, 2024.
Performance
ELV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ELV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.7% | -19.5% | -15.3% |
| 3 y3 years | +0.8% | +6.2% | -8.0% |
| 5 y5 years | +30.6% | -22.2% | -4.3% |
ELV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.7% | +0.8% | -19.5% | +166.1% | -15.3% | at low |
| 5 y | 5-year | -1.7% | +30.6% | -22.2% | +283.4% | -15.3% | +27.2% |
| alltime | all time | -1.7% | +863.8% | -40.3% | +1141.6% | -15.3% | +3872.1% |
ELV EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $2.67B(-15.7%) | $8.55B(-7.1%) |
| Mar 2025 | - | $3.17B(+215.7%) | $9.20B(-1.1%) |
| Dec 2024 | $9.30B(-1.7%) | $1.00B(-41.0%) | $9.30B(-4.3%) |
| Sep 2024 | - | $1.70B(-48.8%) | $9.72B(-3.7%) |
| Jun 2024 | - | $3.32B(+1.6%) | $10.10B(+4.6%) |
| Mar 2024 | - | $3.27B(+129.5%) | $9.65B(+2.0%) |
| Dec 2023 | $9.46B(+2.0%) | $1.43B(-31.5%) | $9.46B(-1.0%) |
| Sep 2023 | - | $2.08B(-27.6%) | $9.55B(-5.0%) |
| Jun 2023 | - | $2.87B(-6.7%) | $10.05B(+3.7%) |
| Mar 2023 | - | $3.08B(+103.0%) | $9.69B(+4.5%) |
| Dec 2022 | $9.28B(+0.5%) | $1.52B(-41.1%) | $9.28B(-2.5%) |
| Sep 2022 | - | $2.58B(+2.5%) | $9.52B(+2.5%) |
| Jun 2022 | - | $2.52B(-5.6%) | $9.29B(-1.6%) |
| Mar 2022 | - | $2.66B(+51.4%) | $9.43B(+2.2%) |
| Dec 2021 | $9.23B(+24.8%) | $1.76B(-25.0%) | $9.23B(+10.3%) |
| Sep 2021 | - | $2.35B(-11.8%) | $8.37B(+24.6%) |
| Jun 2021 | - | $2.66B(+8.3%) | $6.72B(-10.3%) |
| Mar 2021 | - | $2.46B(+172.8%) | $7.49B(+1.3%) |
| Dec 2020 | $7.39B(+3.8%) | $901.00M(+29.3%) | $7.39B(-5.7%) |
| Sep 2020 | - | $697.00M(-79.7%) | $7.83B(-12.2%) |
| Jun 2020 | - | $3.44B(+45.6%) | $8.93B(+23.3%) |
| Mar 2020 | - | $2.36B(+75.5%) | $7.24B(+1.8%) |
| Dec 2019 | $7.12B(+14.8%) | $1.34B(-24.9%) | $7.12B(+7.8%) |
| Sep 2019 | - | $1.79B(+2.3%) | $6.61B(+4.1%) |
| Jun 2019 | - | $1.75B(-21.7%) | $6.35B(-0.6%) |
| Mar 2019 | - | $2.23B(+168.8%) | $6.38B(+3.0%) |
| Dec 2018 | $6.20B(+27.7%) | $831.00M(-45.7%) | $6.20B(+8.4%) |
| Sep 2018 | - | $1.53B(-14.5%) | $5.72B(+3.4%) |
| Jun 2018 | - | $1.79B(-12.7%) | $5.53B(+7.1%) |
| Mar 2018 | - | $2.05B(+482.9%) | $5.17B(+6.5%) |
| Dec 2017 | $4.85B(-11.2%) | $351.70M(-73.8%) | $4.85B(-10.0%) |
| Sep 2017 | - | $1.34B(-5.8%) | $5.39B(-0.4%) |
| Jun 2017 | - | $1.42B(-17.9%) | $5.42B(-4.4%) |
| Mar 2017 | - | $1.74B(+94.8%) | $5.67B(+3.6%) |
| Dec 2016 | $5.47B(-1.3%) | $891.00M(-34.7%) | $5.47B(+5.5%) |
| Sep 2016 | - | $1.36B(-18.5%) | $5.18B(+5.4%) |
| Jun 2016 | - | $1.67B(+8.9%) | $4.92B(-7.1%) |
| Mar 2016 | - | $1.54B(+153.8%) | $5.29B(-4.4%) |
| Dec 2015 | $5.54B(+6.1%) | $605.60M(-45.0%) | $5.54B(-8.1%) |
| Sep 2015 | - | $1.10B(-46.3%) | $6.03B(-3.2%) |
| Jun 2015 | - | $2.05B(+14.9%) | $6.23B(+10.1%) |
| Mar 2015 | - | $1.78B(+62.8%) | $5.66B(+8.4%) |
| Dec 2014 | $5.22B | $1.10B(-15.8%) | $5.22B(+8.2%) |
| Sep 2014 | - | $1.30B(-11.9%) | $4.82B(+4.1%) |
| Jun 2014 | - | $1.48B(+9.6%) | $4.63B(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $1.35B(+93.1%) | $4.59B(-3.1%) |
| Dec 2013 | $4.75B(+3.3%) | $697.50M(-37.2%) | $4.74B(+0.5%) |
| Sep 2013 | - | $1.11B(-22.7%) | $4.72B(-2.1%) |
| Jun 2013 | - | $1.44B(-3.9%) | $4.82B(+4.5%) |
| Mar 2013 | - | $1.49B(+121.6%) | $4.61B(+0.1%) |
| Dec 2012 | $4.60B(+0.1%) | $674.50M(-44.4%) | $4.61B(+0.4%) |
| Sep 2012 | - | $1.21B(-1.5%) | $4.59B(+0.3%) |
| Jun 2012 | - | $1.23B(-17.3%) | $4.57B(+1.5%) |
| Mar 2012 | - | $1.49B(+126.2%) | $4.51B(-1.9%) |
| Dec 2011 | $4.60B(-7.3%) | $658.00M(-45.0%) | $4.60B(-5.2%) |
| Sep 2011 | - | $1.20B(+3.0%) | $4.85B(-1.9%) |
| Jun 2011 | - | $1.16B(-26.3%) | $4.94B(-2.3%) |
| Mar 2011 | - | $1.58B(+73.3%) | $5.06B(+2.1%) |
| Dec 2010 | $4.95B(-37.7%) | $910.40M(-29.6%) | $4.95B(-41.9%) |
| Sep 2010 | - | $1.29B(+1.2%) | $8.52B(+0.4%) |
| Jun 2010 | - | $1.28B(-13.4%) | $8.48B(+1.0%) |
| Mar 2010 | - | $1.47B(-67.1%) | $8.40B(+5.6%) |
| Dec 2009 | $7.96B(+115.4%) | $4.48B(+256.3%) | $7.96B(+93.0%) |
| Sep 2009 | - | $1.26B(+5.2%) | $4.12B(+15.7%) |
| Jun 2009 | - | $1.19B(+16.0%) | $3.56B(-3.7%) |
| Mar 2009 | - | $1.03B(+60.2%) | $3.70B(+0.1%) |
| Dec 2008 | $3.69B(-36.8%) | $642.60M(-7.7%) | $3.69B(-18.2%) |
| Sep 2008 | - | $696.20M(-47.7%) | $4.52B(-15.4%) |
| Jun 2008 | - | $1.33B(+30.0%) | $5.34B(-2.5%) |
| Mar 2008 | - | $1.02B(-30.2%) | $5.48B(-6.3%) |
| Dec 2007 | $5.84B(+5.9%) | $1.47B(-3.4%) | $5.84B(+0.5%) |
| Sep 2007 | - | $1.52B(+3.4%) | $5.82B(+2.0%) |
| Jun 2007 | - | $1.47B(+5.6%) | $5.70B(+2.1%) |
| Mar 2007 | - | $1.39B(-3.3%) | $5.59B(+1.3%) |
| Dec 2006 | $5.52B(+22.0%) | $1.44B(+2.3%) | $5.52B(+4.6%) |
| Sep 2006 | - | $1.41B(+3.9%) | $5.28B(+4.5%) |
| Jun 2006 | - | $1.35B(+2.5%) | $5.05B(+5.9%) |
| Mar 2006 | - | $1.32B(+10.3%) | $4.77B(+5.5%) |
| Dec 2005 | $4.52B(+162.7%) | $1.20B(+1.5%) | $4.52B(+18.2%) |
| Sep 2005 | - | $1.18B(+10.0%) | $3.83B(+27.8%) |
| Jun 2005 | - | $1.07B(0.0%) | $3.00B(+27.6%) |
| Mar 2005 | - | $1.07B(+114.1%) | $2.35B(+36.0%) |
| Dec 2004 | $1.72B(+17.6%) | $501.20M(+44.1%) | $1.73B(+40.9%) |
| Sep 2004 | - | $347.90M(-18.3%) | $1.23B(+39.7%) |
| Jun 2004 | - | $425.90M(-5.6%) | $877.30M(+94.4%) |
| Mar 2004 | - | $451.40M(+38.7%) | $451.40M(-44.6%) |
| Dec 2003 | $1.46B(+51.8%) | - | - |
| Dec 2002 | $964.60M | $325.40M(+18.5%) | $815.10M(+66.4%) |
| Sep 2002 | - | $274.50M(+27.6%) | $489.70M(+127.6%) |
| Jun 2002 | - | $215.20M | $215.20M |
FAQ
- What is Elevance Health, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Elevance Health, Inc.?
- What is Elevance Health, Inc. annual EBITDA year-on-year change?
- What is Elevance Health, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Elevance Health, Inc.?
- What is Elevance Health, Inc. quarterly EBITDA year-on-year change?
- What is Elevance Health, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Elevance Health, Inc.?
- What is Elevance Health, Inc. TTM EBITDA year-on-year change?
What is Elevance Health, Inc. annual EBITDA?
The current annual EBITDA of ELV is $9.30B
What is the all time high annual EBITDA for Elevance Health, Inc.?
Elevance Health, Inc. all-time high annual EBITDA is $9.46B
What is Elevance Health, Inc. annual EBITDA year-on-year change?
Over the past year, ELV annual EBITDA has changed by -$163.00M (-1.72%)
What is Elevance Health, Inc. quarterly EBITDA?
The current quarterly EBITDA of ELV is $2.67B
What is the all time high quarterly EBITDA for Elevance Health, Inc.?
Elevance Health, Inc. all-time high quarterly EBITDA is $4.48B
What is Elevance Health, Inc. quarterly EBITDA year-on-year change?
Over the past year, ELV quarterly EBITDA has changed by -$649.00M (-19.54%)
What is Elevance Health, Inc. TTM EBITDA?
The current TTM EBITDA of ELV is $8.55B
What is the all time high TTM EBITDA for Elevance Health, Inc.?
Elevance Health, Inc. all-time high TTM EBITDA is $10.10B
What is Elevance Health, Inc. TTM EBITDA year-on-year change?
Over the past year, ELV TTM EBITDA has changed by -$1.55B (-15.33%)